Research Reports

1-4 of 4

• 

  RestartResume

  Roflumilast Cream, 0.15%, for Atopic Dermatitis

  RestartResume

  Roflumilast Cream, 0.15%, for Atopic Dermatitis

  December 2024

  Roflumilast Cream, 0.15%, for Atopic Dermatitis

  Brianna A. Green, BS; Peter A. Lio, MD

  Brianna A. Green, BS; Peter A. Lio, MD

• 

  RestartResume

  Collagen in Atopic Dermatitis 

  RestartResume

  Collagen in Atopic Dermatitis 

  Atopic Dermatitis

  Collagen in Atopic Dermatitis 

  Peter A. Lio, MD; Kripa Ahuja, MS

  Peter A. Lio, MD; Kripa Ahuja, MS

• 

  RestartResume

  Oral Vitamin D Supplementation and Psoriasis Severity

  RestartResume

  Oral Vitamin D Supplementation and Psoriasis Severity

  Research Reports

  Oral Vitamin D Supplementation and Psoriasis Severity

  Peter Lio, MD; Aileen Park, BS

  Peter Lio, MD; Aileen Park, BS

• 

  RestartResume

  Journal Club: Does the Epithelial Barrier Hypothesis Explain the Increase In Allergy, Autoimmunity, and Other Chronic Conditions?

  RestartResume

  Journal Club: Does the Epithelial Barrier Hypothesis Explain the Increase In Allergy, Autoimmunity, and Other Chronic Conditions?

  Research Reports

  Journal Club: Does the Epithelial Barrier Hypothesis Explain the Increase In Allergy, Autoimmunity, and Other Chronic Conditions?

  Peter Lio, MD; Dominique Butler

  Peter Lio, MD; Dominique Butler